Which Phenotypes Should We Include in the Hypoplastic Left Heart Syndrome?

Robert H Anderson1, Diane E Spicer2, Adrian Crucean3

  • 1Biosciences Division, Newcastle University, Newcastle-upon-Tyne, UK.

Insights

The integrity of the ventricular septum is key to distinguishing hypoplastic left heart syndrome (HLHS) from related anomalies. This criterion helps classify HLHS phenotypes based on acquired fetal conditions and the timing of left ventricular growth cessation.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Developmental Biology

Background:

  • A recent special issue on hypoplastic left heart syndrome (HLHS) lacked focus on ventricular septal integrity for phenotype distinction.
  • Differentiating HLHS from related anomalies requires clear criteria for classifying specific cardiac malformations.

Purpose of the Study:

  • To propose the integrity of the ventricular septum as a primary criterion for distinguishing HLHS phenotypes.
  • To re-evaluate the classification of HLHS and related anomalies based on developmental timing.

Main Methods:

  • Review of existing evidence on HLHS and related congenital heart defects.
  • Analysis of the role of ventricular septal integrity in cardiac development.
  • Comparative evaluation of different HLHS phenotypes based on proposed criteria.

Main Results:

  • The integrity of the ventricular septum serves as a crucial distinguishing feature between HLHS and related anomalies.
  • Phenotypes within HLHS can be categorized by the timing of left ventricular growth arrest relative to cardiac development, post-septum closure.
  • Specific recognized combinations include aortic/mitral atresia, mitral stenosis with aortic atresia, and combined mitral/aortic stenosis.

Conclusions:

  • Classifying HLHS based on ventricular septal integrity and developmental timing offers a refined understanding of these complex congenital heart defects.
  • This approach aids in recognizing the spectrum of lesions, including the hypoplastic left heart complex, and their origins as acquired fetal conditions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
22
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
207
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22